全体要約
2023年のグローバルオクトレオチド市場は300万米ドルと評価され、2030年には200万米ドルに調整される見込みで、CAGRは-2.9%です。
市場の成長には、製品の差別化、コスト削減、サプライチェーンの最適化が重要です。主要企業にはノバルティス、サンファーマ、ティアンタイシャン製薬などがあり、上位5社で90%以上のシェアを占めています。
欧州が65%以上のシェアを持つ最大市場で、インドと中国が30%以上を占めています。オクトレオチドは、成長ホルモンやインスリンの抑制に優れたオクタペプチドで、注射剤や粉末の形態で提供されます。
関連する質問
300万米ドル（2023年）
-2.9%（2023年から2030年）
ノバルティス, サンファーマ, 成都天台山製薬, シノファームA-シンク製薬, 四環製薬, 上海ソーホー・イミン製薬, 宜賓製薬
製品の差別化, コスト削減, サプライチェーンの最適化
概要
この調査報告書は、世界のオクトレオチド市場の成長潜在能力を強調しています。オクトレオチドは、今後の市場で安定した成長を示すと予想されています。しかし、製品の差別化、コスト削減、そしてサプライチェーンの最適化は、オクトレオチドの普及にとって重要です。市場のプレーヤーは、研究開発に投資し、戦略的パートナーシップを結び、進化する消費者の好みに合わせて提供を調整する必要があります。そうすることで、オクトレオチド市場によって提示される巨大な機会を活用することができるでしょう。
オクトレオチドは天然のソマトスタチンを薬理学的に模倣するオクタペプチドです。これは、自然ホルモンよりも成長ホルモン、グルカゴン、インスリンのより強力な阻害剤です。通常は酢酸の塩の形をしています。
グローバルオクトレオチドの主要企業には、ノバルティス、SUN、天台山製薬、三生製薬A-Think、シフアン製薬などがあります。グローバルな上位5社は90%以上のシェアを持っています。
ヨーロッパは最大の市場で、シェアは65％を超えています。インドと中国が続き、どちらもシェアは30％を超えています。
主な特徴：
オクトレオチド市場に関する報告は、さまざまな側面を反映し、業界への貴重な洞察を提供します。
市場規模と成長：この研究報告書は、オクトレオチド市場の現在の規模と成長の概要を提供します。歴史的データ、タイプ別の市場セグメンテーション（例：オクトレオチド注射、オクトレオチド粉末）、および地域別の内訳が含まれる場合があります。
市場の推進要因と課題：本レポートでは、政府の規制、環境問題、技術革新、消費者の嗜好の変化など、オクトレオチド市場の成長を促進する要因を特定し、分析することができます。また、インフラの制約、レンジアナイティ、初期コストの高さなど、業界が直面する課題についても強調することができます。
競争環境：この調査報告書では、オクトレオチド市場における競争環境の分析が提供されています。主要なプレーヤーのプロフィール、市場シェア、戦略、および製品の提供が含まれています。この報告書では、新興プレーヤーや彼らが市場に与える潜在的な影響についても特筆することができます。
技術の進展：この調査報告書では、オクトレオチド産業における最新の技術の進展について詳しく説明することができます。これには、オクトレオチド技術の進歩、オクトレオチドの新規参入者、オクトレオチドへの新たな投資、そしてオクトレオチドの未来を形作るその他の革新が含まれます。
downstream procumbent preference: 下流の消費者嗜好
customer procumbent behaviour: 顧客の消費行動
adoption trends: 採用傾向
Octreotide market: オクトレオチド市場
influencing customer purchasing decisions: 顧客の購買決定に影響を与える要因
preferences for Octreotide product: オクトレオチド製品の嗜好
政府の政策とインセンティブ：この調査報告書では、オクトレオチド市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、オクトレオチド市場を促進するためのその他の措置の評価が含まれる場合があります。また、報告書では、これらの政策が市場の成長を促進する効果の評価も行っています。
環境影響と持続可能性：この研究報告書は、オクトレオチド市場の環境影響と持続可能性の側面を評価しています。
市場予測と将来の展望：実施された分析に基づき、研究報告書はオクトレオチド産業に関する市場予測と展望を提供します。これには市場規模の予測、成長率、地域トレンド、技術の進展や政策の動向に関する予測が含まれます。
推奨事項と機会：この報告書は、業界関係者、政策立案者、投資家に対する推奨事項で締めくくられています。新興トレンドを活用し、課題を克服し、オクトレオチド市場の成長と発展に貢献するための市場プレーヤーの潜在的な機会を強調しています。
市場セグメンテーション:
オクトレオチド市場は、タイプおよびアプリケーションによって分割されます。2019年から2030年の期間にわたり、セグメント間の成長は、タイプおよびアプリケーション別の消費価値について、ボリュームおよびバリューの観点から正確な計算と予測を提供します。
タイプ別セグメンテーション
オクトレオチド注射
オクトレオ tide 粉末
オクトレオチド微小球
アプリケーション別の細分化
重度の下痢の治療
アクロメガリーの治療
その他
この報告書は、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロフィールが紹介されている企業は、一次専門家から収集した情報や企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
ノバルティス
サンファーマシューティカル
成都天台山製薬
シノファーム A-シンク製薬
シフアン製薬ホールディングスグループ
上海ソーホー・イミン製薬
宜賓薬業
本レポートで扱われている主要な質問
全世界のオクトレオチド市場の10年間の見通しは何ですか？
オクトレオチド市場の成長を促進している要因、世界的および地域別に。
市場および地域ごとに最も急速に成長する技術はどれですか？
オクトレオチドの市場機会はエンド市場の規模によってどのように異なりますか？
オクトレオチドの種類、用途の内訳はどうなっていますか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのオクトレオチド、年間売上、2019年～2030年
2.1.2 オクトレオチドの世界市場の現状分析・将来予測、地理別、2019年、2023年および2030年
2.1.3 オクトレオチドの世界市場の現状分析・将来予測、国・地域別、2019年、2023年および2030年
2.2 オクトレオチドセグメント、タイプ別
2.2.1 オクトレオチド注射液
2.2.2 オクトレオチド粉末
2.2.3 オクトレオチドマイクロスフェア
2.3 オクトレオチドの売上、タイプ別
2.3.1 グローバルにおけるオクトレオチドの売上・市場シェア、タイプ別（2019年～2024年）
2.3.2 オクトレオチドのグローバルレベニュー・市場シェア、タイプ別（2019～2024年）
2.3.3 グローバルのオクトレオチド、販売価格（タイプ別）（2019年～2024年）
2.4 オクトレオチドセグメント、用途別
2.4.1 ひどい下痢の治療
2.4.2 先端巨大症の治療
2.4.3 その他
2.5 オクトレオチドの売上、用途別
2.5.1 グローバルのオクトレオチド、収益・市場シェア（用途別）（2019年～2024年）
2.5.2 オクトレオチドのグローバルレベニュー・市場シェア、用途別（2019～2024年）
2.5.3 グローバルのオクトレオチド、販売価格（用途別）（2019年～2024年）
3 グローバルにおけるオクトレオチド、企業別
3.1 グローバルにおけるオクトレオチド市場のブレークダウンデータ、企業別
3.1.1 グローバルにおけるオクトレオチドの年間売上、企業別（2019年～2024年）
3.1.2 グローバルにおけるオクトレオチドの売上・市場シェア、企業別（2019年～2024年）
3.2 グローバルにおけるオクトレオチドの年間収益、企業別（2019年～2024年）
3.2.1 グローバルにおけるオクトレオチド市場の収益規模、企業別（2019年～2024年）
3.2.2 グローバルにおけるオクトレオチド市場の収益シェア、企業別（2019年～2024年）
3.3 グローバルにおけるオクトレオチドの販売価格、企業別
3.4 オクトレオチドの主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 オクトレオチドの主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供しているオクトレオチド製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2019年～2024年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 オクトレオチドの世界市場過去推移レビュー、地理別
4.1 オクトレオチドの世界市場規模の過去推移、地理別（2019年～2024年）
4.1.1 グローバルにおけるオクトレオチドの年間売上、地理別（2019年～2024年）
4.1.2 グローバルにおけるオクトレオチドの年間収益、地理別（2019年～2024年）
4.2 オクトレオチドの世界市場規模の過去推移、国・地域別（2019年～2024年）
4.2.1 グローバルにおけるオクトレオチドの年間売上、国・地域別（2019年～2024年）
4.2.2 グローバルにおけるオクトレオチドの年間収益、国・地域別（2019年～2024年）
4.3 アメリカズにおけるオクトレオチドの売上成長
4.4 APACにおけるオクトレオチドの売上成長
4.5 ヨーロッパにおけるオクトレオチドの売上成長
4.6 中東・アフリカにおけるオクトレオチドの売上成長
5 アメリカズ
5.1 アメリカズにおけるオクトレオチドの売上、国別
5.1.1 アメリカズにおけるオクトレオチドの売上規模、国別（2019年～2024年）
5.1.2 アメリカズにおけるオクトレオチド市場の収益規模、国別（2019年～2024年）
5.2 アメリカズにおけるオクトレオチドの売上、タイプ別
5.3 アメリカズにおけるオクトレオチドの売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるオクトレオチドの売上、地域別
6.1.1 APACにおけるオクトレオチドの売上規模、地域別（2019年～2024年）
6.1.2 APACにおけるオクトレオチド市場の収益規模、地域別（2019年～2024年）
6.2 APACにおけるオクトレオチドの売上、タイプ別
6.3 APACにおけるオクトレオチドの売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおけるオクトレオチド、国別
7.1.1 ヨーロッパにおけるオクトレオチドの売上規模、国別（2019年～2024年）
7.1.2 ヨーロッパにおけるオクトレオチド市場の収益規模、国別（2019年～2024年）
7.2 ヨーロッパにおけるオクトレオチドの売上、タイプ別
7.3 ヨーロッパにおけるオクトレオチドの売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおけるオクトレオチド、国別
8.1.1 中東・アフリカにおけるオクトレオチドの売上規模、国別（2019年～2024年）
8.1.2 中東・アフリカにおけるオクトレオチド市場の収益規模、国別（2019年～2024年）
8.2 中東・アフリカにおけるオクトレオチドの売上、タイプ別
8.3 中東・アフリカにおけるオクトレオチドの売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 オクトレオチドの製造コスト構造分析
10.3 オクトレオチドの製造プロセス分析
10.4 オクトレオチドのインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 オクトレオチドの流通業者
11.3 オクトレオチドの顧客
12 オクトレオチドの世界市場予測レビュー、地理別
12.1 グローバルにおけるオクトレオチドの市場規模予測、地域別
12.1.1 グローバルのオクトレオチド、市場予測（地域別）（2025年～2030年）
12.1.2 グローバルのオクトレオチド、年間収益予測（地域別）（2025年～2030年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおけるオクトレオチドの市場予測、タイプ別
12.7 グローバルにおけるオクトレオチドの市場予測、用途別
13 キープレイヤー分析
13.1 Novartis
13.1.1 Novartis：企業情報
13.1.2 Novartis：オクトレオチド製品ポートフォリオと特徴
13.1.3 Novartis：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.1.4 Novartis：主要事業概要
13.1.5 Novartis：直近の展開
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical：企業情報
13.2.2 Sun Pharmaceutical：オクトレオチド製品ポートフォリオと特徴
13.2.3 Sun Pharmaceutical：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.2.4 Sun Pharmaceutical：主要事業概要
13.2.5 Sun Pharmaceutical：直近の展開
13.3 Chengdu Tiantaishan pharmaceutical
13.3.1 Chengdu Tiantaishan pharmaceutical：企業情報
13.3.2 Chengdu Tiantaishan pharmaceutical：オクトレオチド製品ポートフォリオと特徴
13.3.3 Chengdu Tiantaishan pharmaceutical：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.3.4 Chengdu Tiantaishan pharmaceutical：主要事業概要
13.3.5 Chengdu Tiantaishan pharmaceutical：直近の展開
13.4 Sinopharm A-Think Pharmaceuticals
13.4.1 Sinopharm A-Think Pharmaceuticals：企業情報
13.4.2 Sinopharm A-Think Pharmaceuticals：オクトレオチド製品ポートフォリオと特徴
13.4.3 Sinopharm A-Think Pharmaceuticals：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.4.4 Sinopharm A-Think Pharmaceuticals：主要事業概要
13.4.5 Sinopharm A-Think Pharmaceuticals：直近の展開
13.5 Sihuan Pharmaceutical Holdings Group
13.5.1 Sihuan Pharmaceutical Holdings Group：企業情報
13.5.2 Sihuan Pharmaceutical Holdings Group：オクトレオチド製品ポートフォリオと特徴
13.5.3 Sihuan Pharmaceutical Holdings Group：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.5.4 Sihuan Pharmaceutical Holdings Group：主要事業概要
13.5.5 Sihuan Pharmaceutical Holdings Group：直近の展開
13.6 Shanghai Soho-Yiming Pharmaceuticals
13.6.1 Shanghai Soho-Yiming Pharmaceuticals：企業情報
13.6.2 Shanghai Soho-Yiming Pharmaceuticals：オクトレオチド製品ポートフォリオと特徴
13.6.3 Shanghai Soho-Yiming Pharmaceuticals：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.6.4 Shanghai Soho-Yiming Pharmaceuticals：主要事業概要
13.6.5 Shanghai Soho-Yiming Pharmaceuticals：直近の展開
13.7 Yibin Pharmaceutical
13.7.1 Yibin Pharmaceutical：企業情報
13.7.2 Yibin Pharmaceutical：オクトレオチド製品ポートフォリオと特徴
13.7.3 Yibin Pharmaceutical：オクトレオチド売上・収益・価格およびグロスマージン（2019年～2024年）
13.7.4 Yibin Pharmaceutical：主要事業概要
13.7.5 Yibin Pharmaceutical：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The research report highlights the growth potential of the global Octreotide market. Octreotide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Octreotide. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Octreotide market.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Key Features:
The report on Octreotide market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Octreotide market. It may include historical data, market segmentation by Type (e.g., Octreotide Injection, Octreotide Powder), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Octreotide market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Octreotide market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Octreotide industry. This include advancements in Octreotide technology, Octreotide new entrants, Octreotide new investment, and other innovations that are shaping the future of Octreotide.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Octreotide market. It includes factors influencing customer ' purchasing decisions, preferences for Octreotide product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Octreotide market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Octreotide market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Octreotide market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Octreotide industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Octreotide market.
Market Segmentation:
Octreotide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segmentation by application
Treating Severe Diarrhea
Treating Acromegaly
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Octreotide market?
What factors are driving Octreotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Octreotide market opportunities vary by end market size?
How does Octreotide break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Octreotide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Octreotide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Octreotide by Country/Region, 2019, 2023 & 2030
2.2 Octreotide Segment by Type
2.2.1 Octreotide Injection
2.2.2 Octreotide Powder
2.2.3 Octreotide Microspheres
2.3 Octreotide Sales by Type
2.3.1 Global Octreotide Sales Market Share by Type (2019-2024)
2.3.2 Global Octreotide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Octreotide Sale Price by Type (2019-2024)
2.4 Octreotide Segment by Application
2.4.1 Treating Severe Diarrhea
2.4.2 Treating Acromegaly
2.4.3 Others
2.5 Octreotide Sales by Application
2.5.1 Global Octreotide Sale Market Share by Application (2019-2024)
2.5.2 Global Octreotide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Octreotide Sale Price by Application (2019-2024)
3 Global Octreotide by Company
3.1 Global Octreotide Breakdown Data by Company
3.1.1 Global Octreotide Annual Sales by Company (2019-2024)
3.1.2 Global Octreotide Sales Market Share by Company (2019-2024)
3.2 Global Octreotide Annual Revenue by Company (2019-2024)
3.2.1 Global Octreotide Revenue by Company (2019-2024)
3.2.2 Global Octreotide Revenue Market Share by Company (2019-2024)
3.3 Global Octreotide Sale Price by Company
3.4 Key Manufacturers Octreotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Octreotide Product Location Distribution
3.4.2 Players Octreotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Octreotide by Geographic Region
4.1 World Historic Octreotide Market Size by Geographic Region (2019-2024)
4.1.1 Global Octreotide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Octreotide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Octreotide Market Size by Country/Region (2019-2024)
4.2.1 Global Octreotide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Octreotide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Octreotide Sales Growth
4.4 APAC Octreotide Sales Growth
4.5 Europe Octreotide Sales Growth
4.6 Middle East & Africa Octreotide Sales Growth
5 Americas
5.1 Americas Octreotide Sales by Country
5.1.1 Americas Octreotide Sales by Country (2019-2024)
5.1.2 Americas Octreotide Revenue by Country (2019-2024)
5.2 Americas Octreotide Sales by Type
5.3 Americas Octreotide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Octreotide Sales by Region
6.1.1 APAC Octreotide Sales by Region (2019-2024)
6.1.2 APAC Octreotide Revenue by Region (2019-2024)
6.2 APAC Octreotide Sales by Type
6.3 APAC Octreotide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Octreotide by Country
7.1.1 Europe Octreotide Sales by Country (2019-2024)
7.1.2 Europe Octreotide Revenue by Country (2019-2024)
7.2 Europe Octreotide Sales by Type
7.3 Europe Octreotide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Octreotide by Country
8.1.1 Middle East & Africa Octreotide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Octreotide Revenue by Country (2019-2024)
8.2 Middle East & Africa Octreotide Sales by Type
8.3 Middle East & Africa Octreotide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Octreotide
10.3 Manufacturing Process Analysis of Octreotide
10.4 Industry Chain Structure of Octreotide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Octreotide Distributors
11.3 Octreotide Customer
12 World Forecast Review for Octreotide by Geographic Region
12.1 Global Octreotide Market Size Forecast by Region
12.1.1 Global Octreotide Forecast by Region (2025-2030)
12.1.2 Global Octreotide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Octreotide Forecast by Type
12.7 Global Octreotide Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Octreotide Product Portfolios and Specifications
13.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Octreotide Product Portfolios and Specifications
13.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Chengdu Tiantaishan pharmaceutical
13.3.1 Chengdu Tiantaishan pharmaceutical Company Information
13.3.2 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolios and Specifications
13.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Chengdu Tiantaishan pharmaceutical Main Business Overview
13.3.5 Chengdu Tiantaishan pharmaceutical Latest Developments
13.4 Sinopharm A-Think Pharmaceuticals
13.4.1 Sinopharm A-Think Pharmaceuticals Company Information
13.4.2 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications
13.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sinopharm A-Think Pharmaceuticals Main Business Overview
13.4.5 Sinopharm A-Think Pharmaceuticals Latest Developments
13.5 Sihuan Pharmaceutical Holdings Group
13.5.1 Sihuan Pharmaceutical Holdings Group Company Information
13.5.2 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications
13.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sihuan Pharmaceutical Holdings Group Main Business Overview
13.5.5 Sihuan Pharmaceutical Holdings Group Latest Developments
13.6 Shanghai Soho-Yiming Pharmaceuticals
13.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
13.6.2 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications
13.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shanghai Soho-Yiming Pharmaceuticals Main Business Overview
13.6.5 Shanghai Soho-Yiming Pharmaceuticals Latest Developments
13.7 Yibin Pharmaceutical
13.7.1 Yibin Pharmaceutical Company Information
13.7.2 Yibin Pharmaceutical Octreotide Product Portfolios and Specifications
13.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Yibin Pharmaceutical Main Business Overview
13.7.5 Yibin Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Octreotide Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Octreotide Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Octreotide Injection Table 4. Major Players of Octreotide Powder Table 5. Major Players of Octreotide Microspheres Table 6. Global Octreotide Sales by Type (2019-2024) & (Gram) Table 7. Global Octreotide Sales Market Share by Type (2019-2024) Table 8. Global Octreotide Revenue by Type (2019-2024) & ($ million) Table 9. Global Octreotide Revenue Market Share by Type (2019-2024) Table 10. Global Octreotide Sale Price by Type (2019-2024) & (USD/Gram) Table 11. Global Octreotide Sales by Application (2019-2024) & (Gram) Table 12. Global Octreotide Sales Market Share by Application (2019-2024) Table 13. Global Octreotide Revenue by Application (2019-2024) Table 14. Global Octreotide Revenue Market Share by Application (2019-2024) Table 15. Global Octreotide Sale Price by Application (2019-2024) & (USD/Gram) Table 16. Global Octreotide Sales by Company (2019-2024) & (Gram) Table 17. Global Octreotide Sales Market Share by Company (2019-2024) Table 18. Global Octreotide Revenue by Company (2019-2024) ($ Millions) Table 19. Global Octreotide Revenue Market Share by Company (2019-2024) Table 20. Global Octreotide Sale Price by Company (2019-2024) & (USD/Gram) Table 21. Key Manufacturers Octreotide Producing Area Distribution and Sales Area Table 22. Players Octreotide Products Offered Table 23. Octreotide Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Octreotide Sales by Geographic Region (2019-2024) & (Gram) Table 27. Global Octreotide Sales Market Share Geographic Region (2019-2024) Table 28. Global Octreotide Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global Octreotide Revenue Market Share by Geographic Region (2019-2024) Table 30. Global Octreotide Sales by Country/Region (2019-2024) & (Gram) Table 31. Global Octreotide Sales Market Share by Country/Region (2019-2024) Table 32. Global Octreotide Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global Octreotide Revenue Market Share by Country/Region (2019-2024) Table 34. Americas Octreotide Sales by Country (2019-2024) & (Gram) Table 35. Americas Octreotide Sales Market Share by Country (2019-2024) Table 36. Americas Octreotide Revenue by Country (2019-2024) & ($ Millions) Table 37. Americas Octreotide Revenue Market Share by Country (2019-2024) Table 38. Americas Octreotide Sales by Type (2019-2024) & (Gram) Table 39. Americas Octreotide Sales by Application (2019-2024) & (Gram) Table 40. APAC Octreotide Sales by Region (2019-2024) & (Gram) Table 41. APAC Octreotide Sales Market Share by Region (2019-2024) Table 42. APAC Octreotide Revenue by Region (2019-2024) & ($ Millions) Table 43. APAC Octreotide Revenue Market Share by Region (2019-2024) Table 44. APAC Octreotide Sales by Type (2019-2024) & (Gram) Table 45. APAC Octreotide Sales by Application (2019-2024) & (Gram) Table 46. Europe Octreotide Sales by Country (2019-2024) & (Gram) Table 47. Europe Octreotide Sales Market Share by Country (2019-2024) Table 48. Europe Octreotide Revenue by Country (2019-2024) & ($ Millions) Table 49. Europe Octreotide Revenue Market Share by Country (2019-2024) Table 50. Europe Octreotide Sales by Type (2019-2024) & (Gram) Table 51. Europe Octreotide Sales by Application (2019-2024) & (Gram) Table 52. Middle East & Africa Octreotide Sales by Country (2019-2024) & (Gram) Table 53. Middle East & Africa Octreotide Sales Market Share by Country (2019-2024) Table 54. Middle East & Africa Octreotide Revenue by Country (2019-2024) & ($ Millions) Table 55. Middle East & Africa Octreotide Revenue Market Share by Country (2019-2024) Table 56. Middle East & Africa Octreotide Sales by Type (2019-2024) & (Gram) Table 57. Middle East & Africa Octreotide Sales by Application (2019-2024) & (Gram) Table 58. Key Market Drivers & Growth Opportunities of Octreotide Table 59. Key Market Challenges & Risks of Octreotide Table 60. Key Industry Trends of Octreotide Table 61. Octreotide Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Octreotide Distributors List Table 64. Octreotide Customer List Table 65. Global Octreotide Sales Forecast by Region (2025-2030) & (Gram) Table 66. Global Octreotide Revenue Forecast by Region (2025-2030) & ($ millions) Table 67. Americas Octreotide Sales Forecast by Country (2025-2030) & (Gram) Table 68. Americas Octreotide Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. APAC Octreotide Sales Forecast by Region (2025-2030) & (Gram) Table 70. APAC Octreotide Revenue Forecast by Region (2025-2030) & ($ millions) Table 71. Europe Octreotide Sales Forecast by Country (2025-2030) & (Gram) Table 72. Europe Octreotide Revenue Forecast by Country (2025-2030) & ($ millions) Table 73. Middle East & Africa Octreotide Sales Forecast by Country (2025-2030) & (Gram) Table 74. Middle East & Africa Octreotide Revenue Forecast by Country (2025-2030) & ($ millions) Table 75. Global Octreotide Sales Forecast by Type (2025-2030) & (Gram) Table 76. Global Octreotide Revenue Forecast by Type (2025-2030) & ($ Millions) Table 77. Global Octreotide Sales Forecast by Application (2025-2030) & (Gram) Table 78. Global Octreotide Revenue Forecast by Application (2025-2030) & ($ Millions) Table 79. Novartis Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 80. Novartis Octreotide Product Portfolios and Specifications Table 81. Novartis Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 82. Novartis Main Business Table 83. Novartis Latest Developments Table 84. Sun Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 85. Sun Pharmaceutical Octreotide Product Portfolios and Specifications Table 86. Sun Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 87. Sun Pharmaceutical Main Business Table 88. Sun Pharmaceutical Latest Developments Table 89. Chengdu Tiantaishan pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 90. Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolios and Specifications Table 91. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 92. Chengdu Tiantaishan pharmaceutical Main Business Table 93. Chengdu Tiantaishan pharmaceutical Latest Developments Table 94. Sinopharm A-Think Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 95. Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolios and Specifications Table 96. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 97. Sinopharm A-Think Pharmaceuticals Main Business Table 98. Sinopharm A-Think Pharmaceuticals Latest Developments Table 99. Sihuan Pharmaceutical Holdings Group Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 100. Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolios and Specifications Table 101. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 102. Sihuan Pharmaceutical Holdings Group Main Business Table 103. Sihuan Pharmaceutical Holdings Group Latest Developments Table 104. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 105. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolios and Specifications Table 106. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 107. Shanghai Soho-Yiming Pharmaceuticals Main Business Table 108. Shanghai Soho-Yiming Pharmaceuticals Latest Developments Table 109. Yibin Pharmaceutical Basic Information, Octreotide Manufacturing Base, Sales Area and Its Competitors Table 110. Yibin Pharmaceutical Octreotide Product Portfolios and Specifications Table 111. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue ($ Million), Price (USD/Gram) and Gross Margin (2019-2024) Table 112. Yibin Pharmaceutical Main Business Table 113. Yibin Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Octreotide Figure 2. Octreotide Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Octreotide Sales Growth Rate 2019-2030 (Gram) Figure 7. Global Octreotide Revenue Growth Rate 2019-2030 ($ Millions) Figure 8. Octreotide Sales by Region (2019, 2023 & 2030) & ($ Millions) Figure 9. Product Picture of Octreotide Injection Figure 10. Product Picture of Octreotide Powder Figure 11. Product Picture of Octreotide Microspheres Figure 12. Global Octreotide Sales Market Share by Type in 2023 Figure 13. Global Octreotide Revenue Market Share by Type (2019-2024) Figure 14. Octreotide Consumed in Treating Severe Diarrhea Figure 15. Global Octreotide Market: Treating Severe Diarrhea (2019-2024) & (Gram) Figure 16. Octreotide Consumed in Treating Acromegaly Figure 17. Global Octreotide Market: Treating Acromegaly (2019-2024) & (Gram) Figure 18. Octreotide Consumed in Others Figure 19. Global Octreotide Market: Others (2019-2024) & (Gram) Figure 20. Global Octreotide Sales Market Share by Application (2023) Figure 21. Global Octreotide Revenue Market Share by Application in 2023 Figure 22. Octreotide Sales Market by Company in 2023 (Gram) Figure 23. Global Octreotide Sales Market Share by Company in 2023 Figure 24. Octreotide Revenue Market by Company in 2023 ($ Million) Figure 25. Global Octreotide Revenue Market Share by Company in 2023 Figure 26. Global Octreotide Sales Market Share by Geographic Region (2019-2024) Figure 27. Global Octreotide Revenue Market Share by Geographic Region in 2023 Figure 28. Americas Octreotide Sales 2019-2024 (Gram) Figure 29. Americas Octreotide Revenue 2019-2024 ($ Millions) Figure 30. APAC Octreotide Sales 2019-2024 (Gram) Figure 31. APAC Octreotide Revenue 2019-2024 ($ Millions) Figure 32. Europe Octreotide Sales 2019-2024 (Gram) Figure 33. Europe Octreotide Revenue 2019-2024 ($ Millions) Figure 34. Middle East & Africa Octreotide Sales 2019-2024 (Gram) Figure 35. Middle East & Africa Octreotide Revenue 2019-2024 ($ Millions) Figure 36. Americas Octreotide Sales Market Share by Country in 2023 Figure 37. Americas Octreotide Revenue Market Share by Country in 2023 Figure 38. Americas Octreotide Sales Market Share by Type (2019-2024) Figure 39. Americas Octreotide Sales Market Share by Application (2019-2024) Figure 40. United States Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 41. Canada Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 42. Mexico Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 43. Brazil Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 44. APAC Octreotide Sales Market Share by Region in 2023 Figure 45. APAC Octreotide Revenue Market Share by Regions in 2023 Figure 46. APAC Octreotide Sales Market Share by Type (2019-2024) Figure 47. APAC Octreotide Sales Market Share by Application (2019-2024) Figure 48. China Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 49. Japan Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 50. South Korea Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 51. Southeast Asia Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 52. India Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 53. Australia Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 54. China Taiwan Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 55. Europe Octreotide Sales Market Share by Country in 2023 Figure 56. Europe Octreotide Revenue Market Share by Country in 2023 Figure 57. Europe Octreotide Sales Market Share by Type (2019-2024) Figure 58. Europe Octreotide Sales Market Share by Application (2019-2024) Figure 59. Germany Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 60. France Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 61. UK Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 62. Italy Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 63. Russia Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 64. Middle East & Africa Octreotide Sales Market Share by Country in 2023 Figure 65. Middle East & Africa Octreotide Revenue Market Share by Country in 2023 Figure 66. Middle East & Africa Octreotide Sales Market Share by Type (2019-2024) Figure 67. Middle East & Africa Octreotide Sales Market Share by Application (2019-2024) Figure 68. Egypt Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 69. South Africa Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 70. Israel Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 71. Turkey Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 72. GCC Country Octreotide Revenue Growth 2019-2024 ($ Millions) Figure 73. Manufacturing Cost Structure Analysis of Octreotide in 2023 Figure 74. Manufacturing Process Analysis of Octreotide Figure 75. Industry Chain Structure of Octreotide Figure 76. Channels of Distribution Figure 77. Global Octreotide Sales Market Forecast by Region (2025-2030) Figure 78. Global Octreotide Revenue Market Share Forecast by Region (2025-2030) Figure 79. Global Octreotide Sales Market Share Forecast by Type (2025-2030) Figure 80. Global Octreotide Revenue Market Share Forecast by Type (2025-2030) Figure 81. Global Octreotide Sales Market Share Forecast by Application (2025-2030) Figure 82. Global Octreotide Revenue Market Share Forecast by Application (2025-2030)
